Category: PHAGE THERAPY

Discover the latest in Phage Therapy, where groundbreaking research and clinical advancements converge. Dive into the evolving landscape of phage therapy, a promising approach harnessing bacteriophages to combat bacterial infections. Explore updates on clinical trials, case studies, and regulatory developments shaping this innovative field. Whether you’re a healthcare professional, researcher, or curious reader, our comprehensive coverage keeps you informed about the forefront of phage therapy and its potential to revolutionise healthcare.

Opportunity to work on developing biosensors to detect phage replication

December 17, 2024

When phages kill bacteria, they cause changes in the bacterial membrane that can be detected using electrical impedance spectroscopy. This project aims to develop…

Opportunity to work on ZombiePhage: how do bacterial viruses evolve into useful weapons?

December 15, 2024

Prophages are parasitic genetic elements that integrate within the genomes of bacterial hosts, bursting out with deadly effects in response to stress. Intriguingly, host bacteria…

Opportunity to work as a Senior Scientist, NextGen Sequencing (NGS) Assay Development for Crawford Lab

December 14, 2024

The lab of Jeremy Chase Crawford in the Department of Host-Microbe Interactions is seeking a highly skilled Sr. Scientist to develop and implement novel…

Opportunity to work as a research technician at UCL

December 11, 2024

Looking for an enthusiastic and experienced research technician to join the Therapeutic Vulnerabilities in Solid Tumors and Sarcoma group of Dr Sophie Postel-Vinay and the…

Oppotunity for PhD or Post-Doc in Bacteriophage Engineering at VIB-VUB Center for Structural Biology

December 10, 2024

A major limitation of phage therapy is the typically very narrow host ranges of phages that are isolated from nature. This means that novel…

Phd Opportunity in Combined Therapeutic Efficacy of Phages and Probiotics to Control Avian Pathogenic Escherichia Coli

December 9, 2024

Colibacillosis is one of the most common and important diseases in poultry production often linked to extra-intestinal colonization of avian pathogenic Escherichia coli (APEC)….

PhD opportunity to work on Combinations of bacteriophages and cold plasma for biofilm biocontrol

December 4, 2024

The ongoing antimicrobial resistance crisis has incentivised research into alternative antibacterial and antibiofilm agents. One of them is cold plasma and plasma-activated water (PAW),…

PhD Opportunity in using experimental evolution to understand the impact of phage therapy on Clostridioides difficile

December 1, 2024

C. difficile is intrinsically resistant to many antibiotics and thrives in the disrupted gut environment created by antibiotic treatment. C. difficile is a spore-forming…

PhD Opportunity to work on efficacy of phage cocktails for eradicating MDR E.coli from the GI tract of colonised livestock species

November 29, 2024

Examples of common E. coli bacterial diseases include colibacillosis in chickens and swine caused by avian pathogenic E. coli (APEC) and enterotoxigenic E. coli…

PhD opportunity to work on impact of Hypermutability and Restriction-Modification by Campylobacter jejuni, on Bacteriophage Control Measures

November 26, 2024

Campylobacter jejuni is a major foodborne pathogen responsible for gastroenteritis every year. The major source of infections by this bacterial pathogen is contaminated poultry products. C….